Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients Marco TampelliniAlfredo BerrutiLuigi Dogliotti Clinical trial 03 May 2006 Pages: 241 - 248
Essiac® and Flor-Essence® herbal tonics stimulate the in vitro growth of human breast cancer cells Kristen S. KulpJennifer L. MontgomeryL. Michelle Bennett OriginalPaper 16 March 2006 Pages: 249 - 259
Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density Shinichi TsutsuiHiroshi InoueMasaki Mori Preclinical study 15 March 2006 Pages: 261 - 266
Clinicopathologic factors associated with false negative FDG–PET in primary breast cancer Rakesh KumarAnil ChauhanAbass Alavi OriginalPaper 23 March 2006 Pages: 267 - 274
Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial Mogens GroenvoldPeter M. FayersHenning T. Mouridsen Clinical trial 16 March 2006 Pages: 275 - 284
Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians A NkondjockA. RobidouxP. Ghadirian Epidemiology 16 March 2006 Pages: 285 - 294
Expression of PEA3 and Lack of Correlation Between PEA3 and HER-2/neu Expression in Breast Cancer Wei-Ya XiaHuang-Chun LienMien-Chie Hung Original report 03 June 2006 Pages: 295 - 301
Increased prevalence of prior breast cancer in women with newly diagnosed diabetes Lorraine L. LipscombePamela J. GoodwinJanet E. Hux Epidemiology 15 March 2006 Pages: 303 - 309
Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases Amit GoyalAnthony Douglas-JonesRobert E Mansel Clinical trial 22 March 2006 Pages: 311 - 314
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth Jana DivisovaIsere KuiatseAdrian V. Lee OriginalPaper 16 March 2006 Pages: 315 - 327
Predictors of local recurrence after conservative surgery and whole-breast irradiation Giampiero Ausili CèfaroDomenico GenovesiMarta Di Nicola Clinical trial 23 March 2006 Pages: 329 - 335
Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer Kyeongmee ParkSehwan HanKyoung-Mee Kim Original report 24 February 2006 Pages: 337 - 342
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective Arti HurriaShari GoldfarbClifford Hudis Clinical trial 16 March 2006 Pages: 343 - 348
Diabetes mellitus and breast cancer: a retrospective population-based cohort study Lorraine L. LipscombePamela J. GoodwinJanet E. Hux Epidemiology 16 March 2006 Pages: 349 - 356
Isolation and characterization of a breast progenitor epithelial cell line with robust DNA damage responses Kate C. ShenFred MillerY. Alan Wang Preclinical study 16 March 2006 Pages: 357 - 364
High Prognostic Significance of Residual Disease After Neoadjuvant Chemotherapy: a Retrospective Study in 710 Patients with Operable Breast Cancer Sophie Catherine AbrialFrédérique Penault-LlorcaPhilippe Chollet Erratum 22 June 2006 Pages: 365 - 365
